Cargando…
Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion
BACKGROUND: Kearns‐Sayre syndrome (KSS) is a rare multisystem mitochondrial disorder characterized by onset before 20 years of age and a typical clinical triad: progressive external ophthalmoplegia, pigmentary retinopathy and cardiac conduction anomalies. In most cases KSS is caused by spontaneous h...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834195/ https://www.ncbi.nlm.nih.gov/pubmed/36181358 http://dx.doi.org/10.1002/mgg3.2059 |
_version_ | 1784868408302501888 |
---|---|
author | Grigalionienė, Kristina Burnytė, Birutė Balkelienė, Danutė Ambrozaitytė, Laima Utkus, Algirdas |
author_facet | Grigalionienė, Kristina Burnytė, Birutė Balkelienė, Danutė Ambrozaitytė, Laima Utkus, Algirdas |
author_sort | Grigalionienė, Kristina |
collection | PubMed |
description | BACKGROUND: Kearns‐Sayre syndrome (KSS) is a rare multisystem mitochondrial disorder characterized by onset before 20 years of age and a typical clinical triad: progressive external ophthalmoplegia, pigmentary retinopathy and cardiac conduction anomalies. In most cases KSS is caused by spontaneous heteroplasmic single large‐scale mitochondrial DNA (mtDNA) deletions. Long‐range polymerase chain reaction (LR‐PCR), next generation sequencing (NGS) and multiplex ligation‐dependent probe amplification (MLPA) are the most widely applied methods for the identification of mtDNA deletions. Here, we report the case of 20‐year‐old male who presented with classic Kearns‐Sayre syndrome, confirmed by novel 5,9 kb mtDNA deletion. METHODS AND RESULTS: LR‐PCR and MLPA methods were applied to identify the mitochondrial DNA deletion for the patient, but the results were conflicting. Molecular analysis using primer walking and Sanger sequencing identified a novel 5888 base pairs mtDNA deletion (NC_012920.1:m.6069_11956del) with CAAC nucleotides repeat sequence at the breakpoints. CONCLUSION: Our study enriched the mtDNA variation spectrum associated with KSS and demonstrated the importance of choosing relevant molecular genetic methods. |
format | Online Article Text |
id | pubmed-9834195 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98341952023-01-13 Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion Grigalionienė, Kristina Burnytė, Birutė Balkelienė, Danutė Ambrozaitytė, Laima Utkus, Algirdas Mol Genet Genomic Med Clinical Reports BACKGROUND: Kearns‐Sayre syndrome (KSS) is a rare multisystem mitochondrial disorder characterized by onset before 20 years of age and a typical clinical triad: progressive external ophthalmoplegia, pigmentary retinopathy and cardiac conduction anomalies. In most cases KSS is caused by spontaneous heteroplasmic single large‐scale mitochondrial DNA (mtDNA) deletions. Long‐range polymerase chain reaction (LR‐PCR), next generation sequencing (NGS) and multiplex ligation‐dependent probe amplification (MLPA) are the most widely applied methods for the identification of mtDNA deletions. Here, we report the case of 20‐year‐old male who presented with classic Kearns‐Sayre syndrome, confirmed by novel 5,9 kb mtDNA deletion. METHODS AND RESULTS: LR‐PCR and MLPA methods were applied to identify the mitochondrial DNA deletion for the patient, but the results were conflicting. Molecular analysis using primer walking and Sanger sequencing identified a novel 5888 base pairs mtDNA deletion (NC_012920.1:m.6069_11956del) with CAAC nucleotides repeat sequence at the breakpoints. CONCLUSION: Our study enriched the mtDNA variation spectrum associated with KSS and demonstrated the importance of choosing relevant molecular genetic methods. John Wiley and Sons Inc. 2022-10-01 /pmc/articles/PMC9834195/ /pubmed/36181358 http://dx.doi.org/10.1002/mgg3.2059 Text en © 2022 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Clinical Reports Grigalionienė, Kristina Burnytė, Birutė Balkelienė, Danutė Ambrozaitytė, Laima Utkus, Algirdas Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion |
title |
Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion |
title_full |
Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion |
title_fullStr |
Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion |
title_full_unstemmed |
Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion |
title_short |
Kearns‐Sayre syndrome case. Novel 5,9 kb mtDNA deletion |
title_sort | kearns‐sayre syndrome case. novel 5,9 kb mtdna deletion |
topic | Clinical Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834195/ https://www.ncbi.nlm.nih.gov/pubmed/36181358 http://dx.doi.org/10.1002/mgg3.2059 |
work_keys_str_mv | AT grigalionienekristina kearnssayresyndromecasenovel59kbmtdnadeletion AT burnytebirute kearnssayresyndromecasenovel59kbmtdnadeletion AT balkelienedanute kearnssayresyndromecasenovel59kbmtdnadeletion AT ambrozaitytelaima kearnssayresyndromecasenovel59kbmtdnadeletion AT utkusalgirdas kearnssayresyndromecasenovel59kbmtdnadeletion |